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Background: One of the most consistent findings from clinical and health services research is the failure to
translate research into practice and policy. As a result of these evidence-practice and policy gaps, patients fail to
benefit optimally from advances in healthcare and are exposed to unnecessary risks of iatrogenic harms, and
healthcare systems are exposed to unnecessary expenditure resulting in significant opportunity costs. Over the last
decade, there has been increasing international policy and research attention on how to reduce the evidence-
practice and policy gap. In this paper, we summarise the current concepts and evidence to guide knowledge
translation activities, defined as T2 research (the translation of new clinical knowledge into improved health). We
structure the article around five key questions: what should be transferred; to whom should research knowledge be
transferred; by whom should research knowledge be transferred; how should research knowledge be transferred;
and, with what effect should research knowledge be transferred?
Discussion: We suggest that the basic unit of knowledge translation should usually be up-to-date systematic
reviews or other syntheses of research findings. Knowledge translators need to identify the key messages for
different target audiences and to fashion these in language and knowledge translation products that are easily
assimilated by different audiences. The relative importance of knowledge translation to different target audiences
will vary by the type of research and appropriate endpoints of knowledge translation may vary across different
stakeholder groups. There are a large number of planned knowledge translation models, derived from different
disciplinary, contextual (i.e., setting), and target audience viewpoints. Most of these suggest that planned knowledge
translation for healthcare professionals and consumers is more likely to be successful if the choice of knowledge
translation strategy is informed by an assessment of the likely barriers and facilitators. Although our evidence on the
likely effectiveness of different strategies to overcome specific barriers remains incomplete, there is a range of
informative systematic reviews of interventions aimed at healthcare professionals and consumers (i.e., patients,
family members, and informal carers) and of factors important to research use by policy makers.
Summary: There is a substantial (if incomplete) evidence base to guide choice of knowledge translation activities
targeting healthcare professionals and consumers. The evidence base on the effects of different knowledge
translation approaches targeting healthcare policy makers and senior managers is much weaker but there are a
profusion of innovative approaches that warrant further evaluation.Background
Globally we spend billions of dollars each year in both the
public and private sectors on biomedical, clinical, and health
services research, undergraduate healthcare professional
training and continuing professional development, quality
improvement, patient safety, and risk management. Despite
this, healthcare systems fail to ensure that effective and
cost-effective programs, services, and drugs get to all of* Correspondence: jgrimshaw@ohri.ca
1Department of Medicine, Clinical Epidemiology Program, Ottawa Hospital
Research Institute, University of Ottawa, 501 Smyth Road, Box 711, Ottawa,
ONK1H 8L6, Canada
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Commons Attribution License (http://creativec
reproduction in any medium, provided the orthose who need them; and healthcare professionals fail to
provide the level of care to which they aspire. One of the
most consistent findings from clinical and health services
research is the failure to translate research into practice and
policy. For example, McGlynn and colleagues observed that
patients in the USA received 55% of recommended care,
and that quality varied by medical condition ranging from
79% of recommended care for senile cataract to 11% of
recommended care for alcohol dependence [1]. Similar
findings have been reported globally in both developed and
developing settings, in both primary care and specialty-
provided care and in care provided by all disciplines [2]. Asral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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benefit optimally from advances in healthcare resulting in
poorer quality of life and loss of productivity both person-
ally and at the societal level.
In addition to the limited use of effective treatments,
there is also evidence that around 20% to 30% of patients
may get care that is not needed or care that could be poten-
tially harmful [3]. Because of these evidence-practice gaps,
patients are exposed to unnecessary risks of iatrogenic
harms and healthcare systems are exposed to unnecessary
expenditure resulting in significant opportunity costs.
Over the last 10 to 15 years, there has been increasing
international policy and research attention on how to re-
duce the evidence-practice and policy gap. Across differ-
ent healthcare systems, different terms describe these
efforts including quality assurance, quality improvement,
knowledge translation, knowledge utilisation, knowledge
transfer and exchange, innovation diffusion, implementa-
tion research, research utilisation, evidence-informed
policy, and evidence-informed health systems [4,5].
These different terms often cover related and overlap-
ping constructs. Commenting on the terminology of
quality assurance in 1982, Donabedian noted that ‘we
have used these words in so many different ways that
we no longer clearly understand each other when we
say them’ [6]. Throughout this paper, we use the term
‘knowledge translation’ which has gained currency in
Canada and globally over the last decade. There are
two main types of translational research. T1 research
refers to the translation of basic biomedical research
into clinical science and knowledge, while T2 research
refers to the translation of this new clinical science
and knowledge into improved health [7]. In this paper, we
refer to T2 research. We define knowledge translation as
‘ensuring that stakeholders are aware of and use research
evidence to inform their health and healthcare decision-
making.’ This definition recognizes that there are a wide
range of stakeholders or target audiences for knowledge
translation, including policy makers, professionals (practi-
tioners), consumers (i.e., patients, family members, and in-
formal carers), researchers, and industry.
While knowledge translation is a relatively new term, the
notion of moving research findings into practice is not new.
It can be traced back to the investigations of French sociolo-
gist Gabriel Tarde at the beginning of the 20th century who
attempted to explain why some innovations are adopted
and spread throughout a society, while others are ignored
[8]. The current conceptualization of knowledge trans-
lation evolved out of several diverse disciplinary per-
spectives, including knowledge utilisation, diffusion of
innovations, technology transfer, evidence-based medi-
cine, and quality improvement [9]. Interest in know-
ledge translation has increased dramatically in recent
years due to recognition that traditional approaches tomoving research into practice, which were predomin-
antly based on education (e.g., continuing professional
development CPD), did not lead to optimal care. In
this paper, based on a previously published monograph
chapter [10], we summarise the current concepts and
evidence to guide knowledge translation activities. We
structure the article around five key questions identi-
fied by Lavis and colleagues [11]:
1. What should be transferred?
2. To whom should research knowledge be transferred?
3. By whom should research knowledge be transferred?
4. How should research knowledge be transferred?
5. With what effect should research knowledge be
transferred?Discussion
What should be transferred?
The increased focus on knowledge translation has
frequently emphasised individual studies as the unit for
knowledge translation. While this may be appropriate
when the targets for knowledge translation are other
researchers or research funders (who need to be aware
of primary research results), we argue that this is
inappropriate when the targets for knowledge translation
are consumers, healthcare professionals, and/or policy
makers. This is because individual studies rarely, by
themselves, provide sufficient evidence for practice and
policy changes. In fact, individual studies may be
misleading due to bias in their conduct or random
variations in their findings, although some exceptionally
large randomised trials may be sufficiently persuasive by
themselves to warrant practice or policy change, e.g., the
Antihypertensive and Lipid-Lowering Treatment to
Prevent Heart Attack Trial (ALLHAT) [12] and the
International Study of Infarct Survival 2 (ISIS-2) Trial
[13].
Ioannidis and colleagues undertook a series of landmark
studies of research exploring the evolution of evidence in
healthcare (summarized in [14]). In both basic and clinical
sciences, they observed the ‘Proteus phenomenon’—that
the first published study on a scientific question may find
the most extravagant effect size and that as further evi-
dence is gathered, effect sizes tend to diminish [14]. They
observed that thousands of observations were required be-
fore estimates of gene disease association became stable
[15]. They also noted that the results of even highly cited
clinical research studies published in major medical and
specialty journals were likely to be contraindicated or
found to be exaggerated with further accumulation of evi-
dence [16]. As a result, Ioannidis and colleagues argued
that replication and evidence synthesis is needed before
knowledge translation [14].
Table 2 Potential target audiences for clinical research
about a drug (adapted from Mowatt et al., 1998 [22])
Stop
use
Stop
use,
Promote
use for
Promote
use for
Promote
widespread
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to be interpreted within the context of global evidence
before deciding whether it is ready for knowledge
translation. In other words, the basic unit of knowledge
translation should be up-to-date systematic reviews or
other syntheses of the global evidence. Greater emphasis
on the results of systematic reviews would increase the
‘signal to noise’ of knowledge translation activities and
may increase the likelihood of their success. Over the last
twenty years, healthcare research funders and healthcare
systems have made considerable investments in knowledge
syntheses, especially those targeting the needs of health-
care practitioners and patients. Examples include the sub-
stantial number of publicly funded national guideline and
health technology programs, The Cochrane Collaboration
[17], and the US funded Evidence-based Practice Centers
[18].
The question ‘What should be transferred?’ also chal-
lenges knowledge translators to identify the key messages
for different target audiences and to fashion these in lan-
guage and knowledge translation products that are easily
assimilated by different audiences. Over the past decade, a
variety of different products have been developed targeting
different audiences (for example, decision aids for patients
[19], clinical practice guidelines for healthcare professionals
[20], and actionable messages [11] and policy briefs [21]
for policy makers).
To whom should research knowledge be transferred?
The relative importance of knowledge translation to dif-
ferent target audiences will vary by the type of research
being translated. For example, primary target audiences
for knowledge translation of the results of basic science
include other researchers and industry; whereas primary
target audiences for knowledge translation of the results
of population health research include other researchers,
administrators, and policy makers (See Table 1).Table 1 Stakeholders for different types of research
Potential
stakeholder
Type of research
Basic Clinical Health
Services
Population
Health
Consumers - +++ +++ -
Professionals - +++ +++ -
Local Administrators - ++ +++ +++
National
Policy Makers
- +++ +++ +++
Regulatory Bodies +++ +++ +++ +++
Industry +++ +++ ++ +
Research Funder +++ +++ +++ +++
Researchers +++ +++ +++ +++
Table Legend:
- Not Relevant.
+ Low Relevance to +++ High Relevance.The relative importance of different target audiences
will also vary by the results of the research [22]. For ex-
ample, the primary target audiences for clinical research
demonstrating lack of benefit or harms from a drug suf-
ficient to warrant its withdrawal might be national policy
makers (including regulatory bodies) and industry.
Whereas, the primary target audiences for clinical re-
search demonstrating benefits from a drug to suggest its
widespread use might be patients, healthcare practi-
tioners, local administrators as well as national policy
makers, and industry (See Table 2).By whom should research knowledge be transferred?
The messenger in knowledge translation efforts may be an
individual (e.g., healthcare practitioner, researcher, or con-
sumer), group, organization, or even healthcare system.
The most appropriate messenger will vary according to the
target audience and research knowledge being transferred.
Shonkoff suggests that in determining ‘who’ should be the
messenger credibility is important [23]. Research supports
this view; Hayward and colleagues found that an authorita-
tive endorsement by a respected physician organization or
physician colleague influenced physicians’ use of clinical
practice guidelines in practice [24]. With public policy
makers, Lavis and colleagues suggest that the most credible
messengers might include organizations of government
officials [11].
Building credibility and acting as a messenger for the
transfer of research knowledge is a time-consuming and
skill-intensive process, making it impossible to use a ‘one
size fits all’ approach to deciding ‘by whom should research
knowledge be transferred’ [11]. Researchers typically carrypromote
research
limited
indications
new
indication
use
Consumers S S P S P
Healthcare
Professionals
S S P P P
Administrators S S P P P
National
Policy Makers
P P P P P
Regulatory
Body
P P P P P
Industry P P P P P
Research
Funders
P
Researchers P
Table Legend:
P= Primary Target Audience.
S = Secondary Target Audience.
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They should, however, only be the messenger when they
have credibility with the target audience, possess the skills
and experience needed to transfer the research knowledge
at hand, and have time and resources to do so. A more ap-
propriate approach to effective and sustainable knowledge
translation may be the development of research knowledge
infrastructures by healthcare systems that address the needs
of their various stakeholders (e.g., consumers, practitioners,
managers, and policy makers). Ellen and colleagues define
research knowledge infrastructure as any instrument
(i.e., programs, tools, devices) implemented in a healthcare
system in order to facilitate access, dissemination, exchange,
and/or use of evidence [25]. Components of research know-
ledge infrastructures are classified into two broad categories:
technological and organizational. Technological compo-
nents include electronic databases and search engines.
Organizational components include documentation specia-
lists, data analysts, knowledge brokers (i.e., individuals who
manage the collaboration between an organization, external
information, and knowledge producers and users), and
training programs (to assist with activities such as searching
for information, quality appraisal, adaption and use of the
research findings) [25,26].
In Canada, some knowledge translation researchers
have invested significant time and financial resources
into building technological (online databases with built-
in search engines) resources that can be used by health-
care systems as part of a research knowledge infrastruc-
ture. Rx for Change is an online database that houses
syntheses of the global evidence from systematic reviews:
on the effectiveness of interventions for improving pre-
scribing by healthcare professionals and medicines use
by consumers; of professional interventions that impact
the delivery of care; and of organizational, financial, and
regulatory interventions that influence professional be-
haviour. The methods used to populate the database par-
allel systematic-review methodology. Rx for Change is
publicly accessible and contains research information
relevant to healthcare professionals, consumers, policy
makers, and researchers [27].
Health Systems Evidence is also an online database, but
primarily targets policy makers and senior managers (and
other individuals responsible for assisting or making public
policy decisions). Common criticisms of systematic reviews
by policy makers include the absence of relevant reviews,
and difficulty accessing and understanding reviews. Health
Systems Evidence addresses these criticisms in order to fa-
cilitate the use of systematic reviews in health systems and
policy decision making. Health Systems Evidence is a re-
pository of syntheses of research evidence about govern-
ance, financial, and delivery arrangements within health
systems, and about implementation strategies that can sup-
port change in health systems. The database containspolicy briefs, overviews of systematic reviews, systematic
reviews, and soon will contain a range of other types of
documents needed in the policymaking process, such as
economic evaluations.
Both databases (Rx for Change and Health Systems Evi-
dence) provide improved access to research information
for consumers, practitioners, and/or policy makers. How-
ever, this access is necessary but not sufficient to ensure
knowledge translation. Effective and sustainable knowledge
translation also requires organizational knowledge infra-
structure components. Ellen and colleagues developed a
research knowledge infrastructure framework that identi-
fied potential organizational components that a healthcare
system could have in its research knowledge infrastructure.
This framework is based on an environmental scan
and scoping review of existing literature. The broad
organizational domains included in the framework are: cli-
mate for research use, research production, activities used
to link research to action including push efforts (i.e., efforts
undertaken by researchers to disseminate research evi-
dence to knowledge users), pull efforts (i.e., efforts by
knowledge users to access and use research evidence), and
exchange efforts (i.e., efforts focused on building and main-
taining relationships between researchers and knowledge
users), and evaluation of efforts [25]. This framework is
currently being evaluated in a study examining knowledge-
translation platforms in 41 countries [25,28].
How should research knowledge be transferred?
Planning for knowledge translation
There are a large number of planned knowledge trans-
lation models, derived from different disciplinary and
contextual viewpoints [29,30]. Most of these suggest
that planned knowledge translation is more likely to be
successful if an assessment of the likely barriers and
facilitators informs the choice of knowledge translation
strategy. In this section, we briefly discuss types of bar-
riers, potential approaches for identifying barriers, and
factors influencing the choice of knowledge translation
intervention.
Identifying barriers to knowledge translation
Common barriers across target groups include issues re-
lating to knowledge management, such as the sheer vol-
ume of research evidence currently produced, access to
research evidence sources, time to read evidence sources
and skills to appraise and understand research evidence.
Over the past twenty years, there has been substantial in-
vestment by many healthcare systems to address these
knowledge management barriers. For example, the con-
duct of systematic reviews and development of clinical
practice guidelines to reduce the volume of research evi-
dence and the time needed to read evidence sources; in-
vestment in electronic libraries of health and public
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evidence; and the development of critical appraisal skills
tools and training to improve research literacy skills.
However while better knowledge management is neces-
sary, it is unlikely by itself to be sufficient to ensure know-
ledge translation because of barriers working at different
levels of healthcare systems, many of which operate at
levels beyond the control of an individual practitioner. For
example, barriers may operate at other levels of a health-
care system including: structural barriers (e.g. financial
disincentives), organizational barriers (e.g. inappropriate
skill mix, lack of facilities or equipment), peer group bar-
riers (e.g. local standards of care not in line with desired
practice), professional (e.g. knowledge, attitudes and skills)
and professional-patient interaction barriers (e.g. commu-
nication and information processing issues). Evidence in
support of this can be found in a structured review of
healthcare professionals’ views on engagement in quality
improvement activities [31]. In this review, Davies and
colleagues concluded that many of the barriers to partici-
pating in quality improvement activities identified by
professionals arise from problems related to working
effectively between and across health professions. This
means that although knowledge management resources
(e.g., more time and more resources) may be necessary
and even helpful, they are unlikely to be sufficient to over-
come the other ‘organizational’ barriers professionals face
to engage in quality improvement (and knowledge transla-
tion) activities [31].
There are diverse methods for identifying potential
barriers including qualitative approaches (individual
interviews, focus groups), surveys and direct observa-
tion [32]. However, there are no standard approaches
available yet. As a result, those involved with know-
ledge translation activities need to use their judgement
about how best to elicit barriers given their under-
standing of the context and potential barriers and
resources available to them.Choosing interventions
Unfortunately, our evidence on the likely effectiveness of
different strategies to overcome specific barriers to
knowledge translation remains incomplete. Individuals
involved in knowledge translation need to: identify modi-
fiable and non-modifiable barriers relating to behavior;
identify potential adopters and practice environments;
and prioritise which barriers to target based upon con-
sideration of ‘mission critical’ barriers. Furthermore, the
potential for addressing these barriers through know-
ledge translation activities (based upon consideration of
the likely mechanisms of action of interventions) and the
resources available for knowledge translation activities
also needs to be addressed.Effectiveness of professional behaviour change strategies
The Cochrane Effective Practice and Organisation of
Care (EPOC) group supports reviews of interventions to
improve healthcare systems and healthcare delivery [33].
It has identified over 7,000 randomised and quasi-experi-
mental studies and conducted 80 systematic reviews of
professional, organisational, financial, and regulatory
interventions within its scope by August 2011.
EPOC has prepared two overviews of systematic
reviews and is currently updating these [34,35]. It has
identified over 300 systematic reviews of professional
behaviour change strategies. In this section, we sum-
marise the results of key Cochrane EPOC reviews,
selected because they are in general of higher quality
and more up-to-date than non-Cochrane systematic
reviews of similar focus [36]. We provide a definition
of each intervention, the likely mechanism of action
of the intervention, and any comments relating to the
practical delivery of the intervention (including the
resources required). The details and findings of the
reviews of the interventions, including the median
and range of effect sizes observed, are presented in
Table 3.
Generally, similar median absolute effect sizes are
reported across the interventions. While one interpretation
might be that the choice of intervention is less important
than doing something/anything (i.e., that the observed
effects are largely non specific (Hawthorne-like) effects), we
do not believe this to be the case. The interquartile range of
absolute effect sizes covers almost 30 percentage points and
varies by intervention (see Table 3). Furthermore, the vari-
ation in observed effects within intervention category (for
example the interquartile range of observed effects in trials
of audit and feedback was +3% to +11% absolute improve-
ments in performance) suggest that the effects of interven-
tions vary presumably related to the degree to which the
mechanism of action of the intervention addresses the
underlying barriers in a study. The interventions also have
very different mechanisms of action, and there is likely to
be confounding within and across reviews. In other words,
researchers are likely to have tested interventions that they
believed likely effective given the particular behaviours and
likely barriers within the context of their study. Finally,
because we are reporting absolute effects some broad com-
monality of effect sizes is to be expected. In general, inter-
ventions are not tested in the expectation of producing
large absolute effect sizes. Most cluster trials are powered
to detect effects in the range of 10 to 20 percent absolute
improvement. Under these circumstances similarity of
observed effects is not surprising.
Printed educational materials
EPOC defines printed educational materials as the
‘distribution of published or printed recommendations
Table 3 Effectiveness of professional behaviour change strategies from selected EPOC systematic reviews
Intervention Number of studies/individuals Effect sizes
Review
Printed
Educational
Materials
12 randomised trials Median absolute improvement of care on
categorical process outcomes (e.g., x-ray
requests, prescribing and smoking cessation
activities) of 4.3% (range −8.0% to +9.6%)
across studies.
11 nonrandomised studies
Farmer
et al. [37]
Educational
Meetings
81 randomised trials (involving more
than 11,000 health professionals)
Median absolute improvement in care of 6.0%
(interquartile range +1.8% to 15.3%).
Forsetlund
et al. [38]
Larger effects were associated with higher
attendance rates, mixed interactive and
didactic meetings and interactive meetings.
Smaller effects were observed for complex
behaviours and for less serious outcomes.
Educational
Outreach
69 randomised trials (involving more
than 15,000 health professionals)
Median absolute improvements in:
•prescribing behaviours (17 comparisons) of
4.8% (interquartile range +3.0% to + 6.5%);O’Brien
et al. [39]
•other behaviours (17 comparisons) of 6.0%
(interquartile range +3.6% to +16.0%).
The effects of educational outreach for
changing more complex behaviours are
less certain.
Local Opinion
Leaders
18 randomised trials (involving more
than 296 hospitals and 318 primary
care physicians)
Median absolute improvement of care of 12.0%
across studies (interquartile range +6.0% to
+14.5%).
Flodgren
et al. [40]
Audit and
Feedback
118 randomised trials Median absolute improvement of care of 5.0%
(interquartile range +3% to +11%).
Jamtvedt
et al. [41]
In general, larger effects were seen if baseline
compliance was low.
Computerized
Reminders
28 randomised trials Median absolute improvement of care of 4.2%
(interquartile range +0.8% to +18.8%).
Shojania
et al. [42]
Comment: Most studies have examined the
effects of relatively simple reminders; the results
of more complex decision support systems,
especially for chronic disease management,
have been less successful.
Tailored
Interventions
26 randomised trials Meta-regression using 12 randomised trials.
Pooled odds ratio of 1.52 (95% CI, 1.27 to
1.82, p< .001)
Baker et al. [43]
G
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audio-visual materials and electronic publications. The
materials may have been delivered personally or
through mass mailings’ [37]. In general, printed educa-
tional materials target knowledge and potential skill
gaps of individual healthcare professionals. While they
could also be used to target motivation when written as
a ‘persuasive communication’ there is little evidence of
them being used in this way. Printed educational
materials are commonly used, have a relatively low cost
and are generally feasible in most settings.
Educational meetings
EPOC defines educational meetings as the ‘participation of
healthcare providers in conferences, lectures, workshops or
traineeships’ [38]. An important distinction is between di-
dactic meetings (that largely target knowledge barriers at
the individual healthcare professional/peer group level) and
interactive workshops (that can target knowledge, attitudes,
and skills at the individual healthcare professional/peer
group level). Educational meetings are commonly used,
with the main cost related to the release time for healthcare
professionals, and are generally feasible in most settings.
Educational outreach
EPOC defines educational outreach or academic detail-
ing as ‘use of a trained person who meets with providers
in their practice settings to give information with the in-
tent of changing the providers’ practice. The information
given may have included feedback on the performance of
the provider(s)’ [39]. Soumerai and Avorn suggest that
educational outreach derives from social marketing
approaches that target an individual’s knowledge and
attitudes [44]. Typically, the detailer aims to get a max-
imum of three messages across during a 10 to 15 minute
meeting with a healthcare provider. The detailer will
tailor their approach to the characteristics of the individ-
ual healthcare provider, and typically use additional pro-
vider behaviour change strategies to reinforce their
message. Most studies of educational outreach have fo-
cused on changing relatively simple behaviours in the
control of individual physician behaviors such as the
choice of drugs to prescribe.
Educational outreach programs have been used across a
wide range of healthcare settings especially to target pre-
scribing behaviours. They require considerable resources
including the costs of detailers and preparation of materi-
als. Nevertheless, Mason and colleagues observed that
educational outreach may still be efficient to change pre-
scribing patterns [45].
Local opinion leaders
EPOC defines local opinion leaders as ‘use of providers
nominated by their colleagues as ‘educationally influential’[40]. The investigators must have explicitly stated that their
colleagues identified the opinion leaders.’ Opinion leader-
ship is the degree to which an individual is able to influ-
ence other individuals’ attitudes or overt behaviour
informally in a desired way with relative frequency. This in-
formal leadership is not a function of the individual’s for-
mal position or status in the system; it is earned and
maintained by the individual’s technical competence, social
accessibility, and conformity to the systems norms. When
compared to their peers, opinion leaders have greater ex-
posure to all forms of external communication, have some-
what higher social status and are more innovative.
However, the most striking feature of opinion leaders is
their unique and influential position in their system’s
communication structure; they are at the centre of
interpersonal communication networks (interconnected
individuals who are linked by patterned flows of infor-
mation). Opinion leaders target the knowledge, atti-
tudes, and social norms of their peer group. The
potential success of opinion leaders is dependent upon
the existence of intact social networks within profes-
sional communities. Grimshaw and colleagues observed
that the existence of such networks varied across com-
munities and settings within the UK [46]. They also
observed that opinion leaders were condition-specific;
in other words, colleagues identified different opinion
leaders for different clinical problems. Doumit also
observed that opinion leaders where not stable over
time [47]. The resources required for opinion leaders
include costs of the identification method, training of
opinion leaders and additional service costs.Audit and feedback
EPOC defines audit and feedback as ‘any summary of
clinical performance of healthcare over a specified period
of time’ to change health professional behaviour, as
indexed by ‘objectively measured professional practice in
a healthcare setting or healthcare outcomes.’ The sum-
mary may also have included recommendations for clin-
ical action. The information may have been obtained
from medical records, computerised databases, or obser-
vations from patients. The subsequent feedback of and
resulting action planning based on the audit summary
are also important elements of an audit and feedback
intervention [41,48]. Adams and colleagues observed
that healthcare professionals often over estimated their
performance by around 20% to 30% [49]. Audit and feed-
back target healthcare provider/peer groups’ perceptions
of current performance levels and is useful to create cogni-
tive dissonance within healthcare professionals as a stimu-
lus for behaviour change. The resources required to deliver
audit and feedback include data abstraction and analysis
costs and dissemination costs. The feasibility of audit and
Grimshaw et al. Implementation Science 2012, 7:50 Page 8 of 17
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tine administrative data for feedback.
Reminders
EPOC defines reminders as ‘patient or encounter specific
information, provided verbally, on paper or on a computer
screen, which is designed or intended to prompt a health
professional to recall information [42]. This would usually
be encountered through their general education, in the
medical records or through interactions with peers, and so
remind them to perform or avoid some action to aid indi-
vidual patient care. Computer aided decision support and
drugs dosage are included.’ Reminders prompt healthcare
professionals to remember to do important items during
professional-patient interactions [50]. The majority of early
studies on computerized reminders were undertaken in
highly computerized US academic health science centres,
and their generalisability to other settings is less certain
[51]. The resources required vary across the delivery mech-
anism. Additionally, there is insufficient knowledge at
present about how to prioritise and optimize reminders.
Tailored interventions
Tailored interventions are ‘strategies to improve profes-
sional practice that are planned taking account of pro-
spectively identified barriers to change’ [43]. Barriers to
change refer to factors that have the potential to impair
the effectiveness of interventions designed to improve
professional behaviour/practice. EPOC classifies barriers
to change into nine categories (information manage-
ment, clinical uncertainty, sense of competence, percep-
tions of liability, patient expectations, standards of
practice, financial disincentives, administrative con-
straints, and other) [52]. In a recent review, Baker and
colleagues assessed the effectiveness of interventions tai-
lored to address identified barriers to change on profes-
sional practice or patient outcomes and found that
tailored interventions are more likely to improve profes-
sional practice (e.g., prescribing and adherence to guide-
line recommendations) than is no intervention or the
dissemination of guidelines or educational materials. Fur-
ther research is needed to determine the effectiveness of
tailored interventions in comparison with other interven-
tions [43].
Multifaceted interventions
EPOC defines multifaceted interventions as ‘any interven-
tion including two or more components.’ Multifaceted
interventions potentially target different barriers in the sys-
tem. Grimshaw and colleagues explored whether there was
a dose response curve for multifaceted interventions and
observed that effect sizes did not necessarily increase with
increasing number of components (Figure 1) [20]. They
also observed that few studies provided any explicitrationale or theoretical base for the choice of intervention.
As a result, it was unclear whether researchers had an a
priori rationale for the choice of components in multifa-
ceted interventions based upon possible causal mechan-
isms or whether a ‘kitchen sink’ approach formed the basis
for the choice. It is plausible that multifaceted interven-
tions built upon a careful assessment of barriers and coher-
ent theoretical base may be more effective than single
interventions. Multifaceted interventions are likely to be
more costly than single interventions. When planning
multifaceted interventions, it is important to carefully con-
sider how components are likely to interact to maximise
benefits.
Effectiveness of knowledge translation strategies focusing
on consumers
The Cochrane Consumers and Communication Review
Group supports systematic reviews of the effects of inter-
ventions (particularly those which focus on information
and communication) which affect consumers’ interac-
tions with healthcare professionals, healthcare services
and healthcare researchers [53]. Outcomes of interest in-
clude effects on people’s knowledge and decision-mak-
ing, healthcare use, experience of healthcare, and health
and wellbeing. They have identified over 7,000 rando-
mised studies and conducted 35 systematic reviews of
interventions and one overview of systematic reviews
[54] within their scope to August 2011.
The Cochrane Consumers and Communication Review
Group have developed a taxonomy for organising inter-
ventions. Categories relevant to knowledge translation
include interventions: to facilitate communication and/
or decision making; to support behaviour change; and to
inform and educate. In this section, we summarize the
range of intervention types relevant to knowledge trans-
lation by consumers. Drawing from the Cochrane
reviews, we present the authors’ definition of each inter-
vention; the details and findings of the reviews are pre-
sented in Table 4.
Interventions to facilitate communication and/or
decision-making
Three interventions to facilitate communication and/or
decision making that have been the focus of Cochrane sys-
tematic reviews are decision aids, personalised risk com-
munication, and communication before consultations.
Decision aids are a type of decision support intervention
designed to help people make choices about health treat-
ment options. Stacey (following O’Connor, who prepared
the first Cochrane review), defines them as interventions
containing ‘detailed, specific, and personalized information
to help people focus on options and outcomes for the pur-
pose of decision making’ [55]. They are important for deci-
sions where there is uncertainty about a specific course of
1628466356N =
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80%
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Figure 1 Effect sizes of multifaceted interventions by number of interventions.
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provision of information to consumers that is personally
relevant to them. It is sometimes used to present and dis-
cuss the risks and benefits of healthcare in general, and of
screening in particular, to consumers. As Edwards and col-
leagues outline, it can be based on a consumer’s own risk
factors for a condition (e.g., their age) or calculated from
their risk factors using epidemiological formulas. In the
latter, the information is often presented as an absolute
risk or as a risk score, or categorised into, for example,
high-, medium-, or low-risk groups. Personalised risk
communication may also be less detailed, for example, a
listing of a consumer’s risk factors to guide discussion and
intervention [56]. In their Cochrane review, Kinnersley
and colleagues operationalise communication before con-
sultations to include any intervention delivered before
consultations, and which has been designed to help consu-
mers (and/or their representatives) address their informa-
tion needs within consultations [57].
Interventions to support behaviour change
One area that continues to challenge the Cochrane Con-
sumers and Communication Review Group is the identi-
fication of effective interventions that support behaviour
change. Four interventions which have been the focus of
Cochrane reviews in this area are: interactive health
communication applications; interventions to enhance
medication adherence; contracts; and new methods of
communication. Interactive health communication appli-
cations, defined by Murray and colleagues, are com-
puter-based (usually web-based) information packagesfor patients that combine health information with at
least one of: social support, decision support, or behav-
iour change support [58]. Interventions to enhance
medication adherence include a wide range of single
and multifaceted interventions; Haynes and colleagues
identified: instruction, counseling, automated telephone
monitoring and counseling, manual telephone follow-
up, family intervention, increasing the convenience of
care, simplified dosing, self-monitoring, reminders, spe-
cial ‘reminder’ pill packaging, dose-dispensing units
and medication charts, appointment and prescription
refill reminders, reinforcement/rewards, medication for-
mulations, crisis intervention, direct observation of
treatments, lay health mentoring, comprehensive
pharmaceutical care services, and psychological therapy
in their Cochrane review [60]. Contracts refer to for-
malised (written or verbal) mutual agreements between
two or more parties [61]. New methods of communi-
cation to date have included communicating DNA-
based disease risk estimates to change health beha-
viours on lifestyle (e.g., smoking, physical activity, diet)
[62] and providing consumers with a visual presenta-
tion (i.e., the source images) of their medical imaging
(i.e., of magnetic resonance imaging, tomography, radi-
ography, and/or ultrasonography) results to increase
consumers’ engagement in health-related behaviours
[63].
Interventions to inform and educate
Two interventions which have been the focus of Cochrane
reviews to ‘inform and educate’ consumers are written
Table 4 Effectiveness of knowledge translation strategies focusing on consumers from selected systematic reviews
Intervention Number of studies Findings (Effectiveness)
Review
Decision Aids 86 randomised trials (involving
more than 20,209 participants)
Compared with usual care, decision aids:
Stacey et al. [55] •improved knowledge and accuracy of risk
perceptions;
•reduced the proportion of people who were passive
in decision-making;
•resulted in a higher proportion of patients achieving
decisions informed and consistent with their values
(when decision aids included an explicit values
clarification component);
•reduced the number of people remaining
undecided;
•reduced decisional conflict;
•decreased the choice of major elective surgery in
favour of conservative options.
Decision aids have no adverse effects on satisfaction
but further research is needed to clarify their effect
on adherence to chosen option, patient-practitioner
communication, cost-effectiveness and use with
developing or lower literacy populations.
Personalised Risk
Communication
22 randomised trials There was weak evidence, consistent with a small
effect, that personalised risk communication
(whether written, spoken or visually presented)
increases uptake of screening tests.Edwards et al. [56]
Communication before
Consultations
33 randomised trials (involving
8244 participants)
Compared with a control, communication before
consultations increased question asking during
consultations. They may also increase patient participation
in consultation and improve patient satisfaction.Kinnersley et al. [57]
Both coaching and written material interventions
produced similar effects on question asking, but
coaching produced a larger increase in patient
satisfaction.
Overall the benefits of ‘communication before
consultations’ interventions were minor.
Interactive Health
Communication
Applications (IHCAs)
(2 reviews)
Murray et al. [58] 24 randomised trials (involving
3739 participants)
IHCAs had a significant positive effect on
knowledge, social support and clinical outcomes.
Bailey et al. [59] 15 randomised trials (involving
3917 participants)
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Table 4 Effectiveness of knowledge translation strategies focusing on consumers from selected systematic reviews (Continued)
Positive effects of IHCAs on knowledge, safer sex
self-efficacy and intentions and sexual health
behavior were found.
Comment: Data were insufficient for meta-analysis
of biological outcomes or analysis of cost-
effectiveness and thus, the effects on these outcome
categories remain unknown.
Interventions to Enhance
Medication Adherence
78 randomised trials Mixed effects were observed for short term and long-
term medication adherence.
Haynes et al. [60] Some, but not all, of the simple interventions, such as
counselling, written information and personal phone
calls, were effective with people on short-term
medication treatments.
The picture for the effectiveness of interventions for
longer-term treatments was mixed; few interventions
showed promise and those that were effective were
complex and multifaceted in nature.
Contracts 30 randomised trials (involving
4691 participants)
Contracts were shown to ‘potentially’ improve
patient adherence (as applied to diagnostic
procedures, therapeutic regimens, and/or a health
promotion or illness prevention initiative).
Bosch-Capblanch et al. [61]
Comment: The result above is based on only half
of the included studies; the effects were not detected
over longer periods.
New Methods
of Communication
(2 reviews)
Marteau et al. [62] 13 randomised trials Little or no effect was shown with respect to
smoking cessation or increasing physical activity. A
small effect was shown for changing diet.(on communicating
DNA-based disease
risk estimates) The intervention showed potential for altering
intentions to change behaviour (in six non-clinical
analogue studies).
Comment: The authors concluded that given the
small number of trials in this area, more research
involving ‘better-quality RCTs’ is needed before
recommending application in practice.
Hollands et al. [63] 9 randomised trials (involving
1371 participants)
Overall, results were mixed:
•a positive effect was found for smoking
cessation (three trials);
•a positive effect was found for skin examination
behaviour (one trial);
•no effect was found for change in physical activity
(one trial).
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(providing visual
feedback on medical
imaging results)
Comment: The authors concluded that due to the
sma umber of trials and the mixed results found,
the ectiveness of communicating medical imaging
resu to change health behaviour is largely
unkn wn and thus, its application in practice is not
yet r ommended.
Written Information
Nicolson et al. [64]
25 randomised trials (involving
4788 participants)
Writ material significantly improved knowledge
of m icines in six of twelve trials. In three of these
six t ls recall of side effects also improved, but
med ines recall significantly improved in only a
mino ty of trials (one of four).
The sults for attitudinal and behavioural outcomes
were ixed.
Com ent: Overall, the authors concluded the
com ned evidence from this review is not sufficient
to sa whether written medicines information is
effec e in changing behaviours related to medicine
takin
Self Management Programmes
Foster et al. [65]
17 randomised trials (involving
7442 participants)
Sma clinically insignificant) short-term
impr ements in pain, disability, fatigue and
depr sion were found.
(Self management programmes
run by lay people)
Posi e effects on confidence to manage and self-
rated ealth were also found.
Ther was no effect on quality of life or use of health
servi s.
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http://www.implementationscience.com/content/7/1/50information and self-management programmes. Written in-
formation is one of the most ubiquitous interventions tar-
geting consumers [64].
Self management programmes have become a major ini-
tiative of government and community organizations in the
area of chronic illness [65]. They promote various strat-
egies for people to take an active approach to managing
their health.
Effectiveness of knowledge translation strategies focusing
on policy makers and senior health service managers
In contrast to the substantial evidence base on the effect-
iveness of knowledge translation strategies targeting
healthcare professionals and consumers, few systematic
reviews exist of interventions evaluating the effects of
knowledge translation strategies for policy makers or se-
nior health service managers. One review, conducted by
Perrier and colleagues, evaluated interventions to increase
the use of systematic reviews by health policy makers and
managers [66]. Two studies were included in the review.
The first study utilized a non-experimental design to report
an intervention where public health policy makers were
offered the opportunity to receive five relevant reviews. At
three months and two years, respectively, 23% and 63% of
respondents reported using at least one of the systematic
reviews to make a policy decision. The second study was a
randomised trial where health departments received one of
three interventions: access to an online registry of system-
atic reviews, tailored messages plus access to the online
registry of systematic reviews, or tailored messages plus ac-
cess to the registry along with a knowledge broker who
worked one-on-one with decision makers over a period of
one year. While none of the interventions showed a signifi-
cant effect on global evidence-informed decision making,
tailored messages plus access to the online registry of sys-
tematic reviews showed a positive significant effect on pub-
lic health policies and programs [66].
Lavis and colleagues conducted a systematic review of
factors that influence the use of research evidence in pub-
lic policy making [67]. Five criteria were used to assess
validity of the included studies: the use of two or more
data collection methods; a random or purposive sampling
strategy; response rate >60%; two or more types of re-
search use are examined; and two or more competing
variables are examined.
A total of 16 studies met the criteria of using two or
more data collection methods. These studies were con-
ducted across a variety of jurisdictions, policy domains,
content areas, and time periods. There was relatively little
consistency in findings. However, two factors emerged
with some frequency as being important to policy makers’
use of research evidence: interactions between researchers
and policy makers in the context of policy networks such
as formal advisory committees and in the context ofinformal relationships; and research that matched the
beliefs, values, interests, or political goals and strategies of
elected officials, social interest groups, and others. Both
factors increased the prospects for research use by policy
makers [67].
The findings from these reviews and other findings have
led to the development of a number of knowledge transla-
tion approaches targeting policy makers and senior health
services managers [28,68,69]. For example, a series of tools
called SUPPORT Tools for evidence-informed health policy
making (STP) were developed to assist policy makers in
using research evidence. These tools were developed by
members of the SUPporting POlicy relevant Reviews and
Trials (SUPPORT) project, an international collaboration
funded by the European Commission’s 6th Framework
[70] (http://www.supportcollaboration.org). The SUP-
PORT tools describe a series of processes to help ensure
that relevant research is identified, appraised and used ap-
propriately by policy makers. The tools address four broad
areas of interest related to policymaking: supporting evi-
dence-informed policymaking [71-73]; identifying needs
for research evidence in relation to clarifying problems,
framing options, and planning implementation [74-76];
finding and assessing evidence from systematic reviews
[77-79] and other kinds of evidence [80,81]; and moving
from research evidence to decisions. The focus in this final
area is on engaging stakeholders in evidence-informed pol-
icymaking [21,82,83] and on addressing how to use re-
search evidence in decisions [84-86]. By focusing on how
to ‘support’ the use of research evidence in health policy-
making, the SUPPORT tools should increase the use of re-
search evidence by policy makers [87].
The SUPPORT tools describe a variety of packaging and
push, facilitating pull, and exchange activities. Packaging
and push activities focus on the activities of researchers to
disseminate their research findings to a broad audience
above and beyond traditional routes of dissemination such
as publication in peer reviewed journals [11]. Examples of
packaging and push activities include: increased emphasis
on knowledge syntheses as the unit for knowledge
translation; actionable messages; graded entry formats
to allow the research user to access the level of detail
that he or she requires (for example, the Canadian
Health Services Research Foundation requires research
reports to have one page of main messages, a three-
page executive summary, and then no more than 25
pages for the complete project); using multiple com-
munication channels tailored to the target audience;
targeted electronic push of information relevant to the
specific needs of research users—examples include the
Contacts, Help, Advice and Information Network (C.H.A.
I.N.) ([88], http://chain.ulcc.ac.uk/chain/ accessed 5 July
2011) and E-watch bulletin on Innovation in Health Ser-
vices (http://www.ohpe.ca/node/2740 accessed 5 July
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development of tools to help research users apply research
findings in their own settings.
Facilitating pull activities focus on the needs of users,
and creating an appetite for research results [11]. Pull ac-
tivities include various training activities to improve policy
makers’ and senior managers’ research literacy and inter-
est. For example, the Canadian Health Services Research
Foundation provides the EXTRA program to train senior
healthcare executives in research application (http://www.
chsrf.ca/Programs/EXTRA.aspx accessed 5 July 2011).
‘One stop’ initiatives such as Health Systems Evidence also
facilitate pull.
Exchange activities focus on building and maintain-
ing new relationships between researchers and policy
makers and senior managers to exchange knowledge
and ideas [69,89]. For example, several research-fund-
ing programs require active participation of decision
makers (sometimes including co-funding by healthcare
organisations) in research teams. The rationale is that
decision makers are more likely to consider research
findings if they are actively involved in the research
conducted in their settings to answer specific contextua-
lized questions. These approaches legitimately focus on
local knowledge translation of individual studies. However,
the results of these studies should still be incorporated into
systematic reviews to judge whether additional knowledge
translation activities should be undertaken outside the con-
text and relationships of the original study. Other exchange
approaches include deliberative dialogues and the use of
knowledge brokers to act as ‘human intermediaries’ be-
tween the world of research and action [69,82,90].
This profusion of approaches to improving knowledge
translation to policy makers and senior healthcare man-
agers highlights the increased recognition of the failure of
traditional diffusion approaches to knowledge translation
for this target group (e.g., [90]). Most of these approaches
have a strong theoretical basis and face validity. However,
it will be important to evaluate their benefits, harms and
costs fully.
With what effect should research knowledge be transferred?
Appropriate endpoints of knowledge translation may vary
across different stakeholder groups. For example, know-
ledge translation targeting policy makers and consumers
should ensure that consideration of research evidence is a
key component of their decision making, but recognize
that there are other legitimate factors (for example, the
policy context for policy makers, values and preferences of
individual patients) that need to considered [91-93]. Thus,
the resulting decision is likely to be evidence-informed but
may not be particularly evidence-based. However, know-
ledge translation targeting professionals should result in
practice that is more evidence-based and is likely to beobservable as reflected in changes in professional beha-
viours and quality indicators.Summary
In this paper, we have attempted to briefly summarise
some of the key concepts and evidence about the effect-
iveness of knowledge translation activities targeting dif-
ferent stakeholder groups. We particularly recommend
the five key questions developed by Lavis and colleagues
as an aide for researchers and others involved in know-
ledge translation when developing knowledge translation
activities [11]. There is a substantial (if incomplete) evi-
dence base to guide choice of knowledge translation ac-
tivities targeting healthcare professionals and patients.
The evidence base on the effects of different knowledge
translation approaches targeting healthcare policy
makers and senior managers is much weaker but there
are a profusion of innovative approaches that warrant
further evaluation.
Grol observed that many current knowledge transla-
tion activities are based on participants’ beliefs, rather
than evidence about the likely effectiveness of different
approaches [94]. Grol challenged healthcare systems to
develop and use a robust evidence base to support the
choice of knowledge translation strategies, arguing, ‘evi-
dence-based medicine should be complemented by evi-
dence-based implementation.’ While we are some way
from achieving this goal, there are grounds for optimism.
Over the past twenty-five years, healthcare systems have
invested heavily in knowledge synthesis activities that fa-
cilitate timely access of evidence. Further, it is possible to
achieve clinically important practice changes by healthcare
professionals and improved patient decision making with
current knowledge translation activities.Competing interests
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